Literature DB >> 15665398

Is there a characteristic lipid profile in Alzheimer's disease?

Marwan Sabbagh1, H Reza Zahiri, Joanne Ceimo, Kimbal Cooper, William Gaul, Donald Connor, D Larry Sparks.   

Abstract

OBJECTIVE: To characterize the lipid profile in Alzheimer's Disease (AD) and to determine whether it differs from the cardiac risk profile.
BACKGROUND: Links between hypercholesterolemia and AD development continue to grow. Presently, limited information exists about the lipid profile characteristics in AD.
METHODS: We examined the lipid profiles (total cholesterol (TC), high-density lipoprotein (HDL), lower-density lipoprotein (LDL), TC/HDL ratio, and triglyceride (TG) levels) of 153 subjects with probable/possible AD (mean age 77.2 +/- 8.6 years, mean MMSE 19.9 +/- 5.6) and 25 non-demented subjects with atherosclerotic heart disease (ASHD) (mean age 73.8 +/- 7.2 years); neither on lipid lowering therapy.
RESULTS: Subjects with TC > 200 mg/dl composed 69% of AD and 72% of ASHD groups. Mean TC was 218.9 +/- 38.9 mg/dl and 218.5 +/- 9.2 mg/dl for AD and ASHD subjects respectively. AD subjects exhibited significantly higher HDL and lower TG and TC/HDL ratios. MMSE did not correlate with any lipid parameters in AD. DISCUSSION: Elevated TC, LDL and TG with normal HDL and TC/HDL ratio characterize the lipid profile in AD, which somewhat overlaps with but may be distinct from the cardiac risk profile. MMSE does not correlate with lipid parameters suggesting no interaction between cholesterol and cognition in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15665398     DOI: 10.3233/jad-2004-6602

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

1.  Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics".

Authors:  Marwan N Sabbagh
Journal:  Alzheimers Dement       Date:  2008-04-21       Impact factor: 21.566

Review 2.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

3.  On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks.

Authors:  Marwan N Sabbagh; Kabir Thind; David Larry Sparks
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

4.  Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort.

Authors:  Laila Abdullah; Cheryl Luis; Daniel Paris; Benoit Mouzon; Ghania Ait-Ghezala; Andrew P Keegan; Duolao Wang; Fiona Crawford; Michael Mullan
Journal:  Mol Med       Date:  2009-08-18       Impact factor: 6.354

5.  KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients.

Authors:  Marwan Sabbagh; Michael Malek-Ahmadi; Ian Levenson; D Larry Sparks
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Increased tau phosphorylation and impaired presynaptic function in hypertriglyceridemic ApoB-100 transgenic mice.

Authors:  Nikolett Lénárt; Viktor Szegedi; Gábor Juhász; Aniko Kasztner; János Horváth; Erika Bereczki; Melinda E Tóth; Botond Penke; Miklós Sántha
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage.

Authors:  Carlos Ramírez; Saleta Sierra; Inmaculada Tercero; Jose Antonio Vázquez; Antonia Pineda; Tatiana Manrique; Javier S Burgos
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

8.  The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs.

Authors:  Lisa M Renzi; Billy R Hammond; Melissa Dengler; Richard Roberts
Journal:  Lipids Health Dis       Date:  2012-02-29       Impact factor: 3.876

9.  Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.

Authors:  Nikolett Lénárt; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Melinda E Tóth; András Harazin; Andrea E Tóth; Csaba Vizler; Zsolt Török; Ana-Maria Pilbat; László Vígh; László G Puskás; Miklós Sántha; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2015-07-17

10.  Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease.

Authors:  Seul Kee Byeon; Anil K Madugundu; Ankit P Jain; Firdous A Bhat; Jae Hun Jung; Santosh Renuse; Jacqueline Darrow; Arnold Bakker; Marilyn Albert; Abhay Moghekar; Akhilesh Pandey
Journal:  Mol Omics       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.